药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Cefprozil
Moexiprilat
Tolvaptan may increase the hyperkalemic activities of Moexiprilat.
Cefprozil
Trandolaprilat
Tolvaptan may increase the hyperkalemic activities of Trandolaprilat.
Cefprozil
Ramiprilat
Tolvaptan may increase the hyperkalemic activities of Ramiprilat.
Cefprozil
Fosinoprilat
Tolvaptan may increase the hyperkalemic activities of Fosinoprilat.
Cefprozil
Benazeprilat
Tolvaptan may increase the hyperkalemic activities of Benazeprilat.
Cefprozil
Delapril
Tolvaptan may increase the hyperkalemic activities of Delapril.
Cefprozil
Zofenopril
Tolvaptan may increase the hyperkalemic activities of Zofenopril.
Cefprozil
Imidapril
Tolvaptan may increase the hyperkalemic activities of Imidapril.
Cefprozil
Enalaprilat
Tolvaptan may increase the hyperkalemic activities of Enalaprilat.
Cefprozil
Temocapril
Tolvaptan may increase the hyperkalemic activities of Temocapril.
Cefprozil
Rescinnamine
Tolvaptan may increase the hyperkalemic activities of Rescinnamine.
Cefprozil
Candesartan
The risk or severity of hyperkalemia can be increased when Tolvaptan is combined with Candesartan.
Cefprozil
Fimasartan
The risk or severity of hyperkalemia can be increased when Tolvaptan is combined with Fimasartan.
Cefprozil
Azilsartan medoxomil
The risk or severity of hyperkalemia can be increased when Tolvaptan is combined with Azilsartan medoxomil.
Cefprozil
Saralasin
The risk or severity of hyperkalemia can be increased when Tolvaptan is combined with Saralasin.
Cefprozil
Tasosartan
The risk or severity of hyperkalemia can be increased when Tolvaptan is combined with Tasosartan.
Cefprozil
Saprisartan
The risk or severity of hyperkalemia can be increased when Tolvaptan is combined with Saprisartan.
Cefprozil
Forasartan
The risk or severity of hyperkalemia can be increased when Tolvaptan is combined with Forasartan.
Cefprozil
Armodafinil
The metabolism of Tolvaptan can be increased when combined with Armodafinil.
Flavoxate
Vibrio cholerae CVD 103-HgR strain live antigen
The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Doripenem.